Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | RAC-alpha serine/threonine-protein kinase | ||
Ligand | BDBM50528409 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1904982 (CHEMBL4407340) | ||
IC50 | 0.980000±n/a nM | ||
Citation | Dong, X; Zhan, W; Zhao, M; Che, J; Dai, X; Wu, Y; Xu, L; Zhou, Y; Zhao, Y; Tian, T; Cheng, G; Jin, Z; Li, J; Shao, Y; He, Q; Yang, B; Weng, Q; Hu, Y Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design. J Med Chem62:7264-7288 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
RAC-alpha serine/threonine-protein kinase | |||
Name: | RAC-alpha serine/threonine-protein kinase | ||
Synonyms: | AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT) | ||
Type: | Enzyme | ||
Mol. Mass.: | 55681.25 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P31749 | ||
Residue: | 480 | ||
Sequence: |
| ||
BDBM50528409 | |||
n/a | |||
Name | BDBM50528409 | ||
Synonyms: | CHEMBL4441825 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H22Cl2F2N4O3 | ||
Mol. Mass. | 499.338 | ||
SMILES | Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@@H]1CN[C@H](CCO)C[C@H]1c1ccc(F)c(F)c1 |r,wU:16.17,19.21,wD:24.27,(5.73,-5.85,;5.41,-7.35,;4,-7.98,;4.16,-9.51,;5.66,-9.83,;6.29,-11.24,;6.44,-8.5,;7.97,-8.34,;9,-9.49,;10.41,-8.86,;10.25,-7.33,;8.75,-7.01,;8.12,-5.6,;11.75,-9.64,;11.74,-11.18,;13.08,-8.87,;14.41,-9.65,;14.41,-11.18,;15.74,-11.96,;17.08,-11.19,;18.41,-11.96,;19.74,-11.2,;21.07,-11.97,;17.08,-9.64,;15.75,-8.88,;15.75,-7.35,;14.42,-6.58,;14.42,-5.03,;15.75,-4.26,;15.74,-2.72,;17.08,-5.03,;18.41,-4.25,;17.09,-6.58,)| | ||
Structure |